HCPCS Code Descriptor:
Injection, mirvetuximab soravtansine-gynx, 1 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
ELAHERE is an Oncology drug manufactured by Immunogen and administered via the Intravenous route of administration. The C Code: C9146 is aligned to the drug ELAHERE.